Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic

Clinical Infectious Diseases

Volumn 55, Issue 12, 2012, Pages 1698-1706

  Rangaka, Molebogeng X ^a,b,c   Wilkinson, Robert J ^b,d,e   Glynn, Judith R ^c   Boulle, Andrew ^a   Van Cutsem, Gilles ^a,f   Goliath, Rene ^b   Mathee, Shaheed ^g   Maartens, Gary ^b  

^a School of Public Health and Family Medicine   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f MÉDECINS SANS FRONTIÈRES   (Switzerland)

^g WESTERN CAPE DEPARTMENT OF AGRICULTURE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID;

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISONIAZID PREVENTIVE THERAPY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREVENTION; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM CULTURE; THERAPY EFFECT; TUBERCULOSIS;

ADULT; AMBULATORY CARE FACILITIES; ANTI-RETROVIRAL AGENTS; AREA UNDER CURVE; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SOUTH AFRICA; TUBERCULOSIS;

EID: 84870194648     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis775     Document Type: Article

References (27)

1. Getahun H, Kittikraisak W, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: Individual participant data meta-Analysis of observational studies. PLoS Med 2011; 8:e1000391.
2. Bassett IV, Wang B, Chetty S, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 2011; 51:823-9.
3. Mtei L, Matee M, Herfort O, et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 2005; 40:1500-7. (Pubitemid 40628639)
4. Dowdy DW, Chaisson RE, Maartens G, Corbett EL, Dorman SE. Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci U S A 2008; 105:11293-8.
5. Stop TB Partnership. Guidelines for intensified tuberculosis casefinding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland: World Health Organization, 2011. Available at: Http://whqlibdoc.who.int/publications/2011/9789241500708- eng.pdf. Accessed 7 December 2011.
6. Granich R, Akolo C, Gunneberg C, et al. Prevention of tuberculosis in people living with HIV. Clin Infect Dis 2011; 50(suppl 3):S215-22.
7. Mohammed A, Ehrlich R, Wood R, Cilliers F, Maartens G. Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy. Int J Tuberc Lung Dis 2004; 8:792-5. (Pubitemid 38747158)
8. Lewis JJ, Charalambous S, Day JH, et al. HIV infection does not affect active case finding of tuberculosis in South African gold miners. Am J Respir Crit Care Med 2009; 180:1271-8.
9. Corbett EL, Zezai A, Cheung YB, et al. Provider-initiated symptom screening for tuberculosis in Zimbabwe: Diagnostic value and the effect of HIV status. Bull World Health Organ 2010; 88:13-21.
10. Corbett EL, Bandason T, Cheung YB, et al. Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med 2007; 4:e22.
11. Ayles H, Schaap A, Nota A, et al. Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: Implications for tuberculosis control in the era of HIV. PLoS One 2009; 4:e5602.
12. Cain KP, McCarthy KD, Heilig CM, et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 2010; 362:707-16.
13. Day JH, Charalambous S, Fielding KL, et al. Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int J Tuberc Lung Dis 2006; 10:523-9. (Pubitemid 43667640)
14. Shah S, Demissie M, Lambert L, et al. Intensified tuberculosis case finding among HIV-infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr 2009; 50:537-45.
15. Kimerling ME, Schuchter J, Chanthol E, et al. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis 2002; 6:988-94.
16. Lawn SD, Edwards DJ, Kranzer K, et al. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 2009; 23:1875-80.
17. South African Department of Health. 2004 national antiretroviral treatment guidelines. Pretoria: South African Department of Health, 2004. Available at: Http://southafrica.usembassy.gov/media/2004-dohart-guidelines.pdf. Accessed 12 August 2012.
18. World Health Organization. Report of a WHO Expert Committee on Physical Status: The use and interpretation of anthropometry. Geneva, Switzerland: WHO, 1995. Available at: Http://whqlibdoc.who.int/trs/WHO-TRS-854.pdf. Accessed 13 September 2011.
19. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22:1897-908.
20. Lawn SD, Myer L, Harling G, et al. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: Implications for program evaluation. Clin Infect Dis 2006; 43:770-6. (Pubitemid 44330743)
21. Lawn SD, Brooks SV, Kranzer K, et al. Screening for HIV-Associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: A prospective study. PLoS Med 2011; 8:e1001067.
22. Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O. Pulmonary tuberculosis among people living with HIV/AIDS attending care and treatment in rural northern Tanzania. BMC Public Health 2008; 8:341.
23. Kufa T, Mngomezulu V, Charalambous S, et al. Undiagnosed tuberculosis among HIV clinic attendees: Association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control. J Acquir Immune Defic Syndr 2012; 60:e22-8.
24. Moore D, Liechty C, Ekwaru P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 2007; 21:713-9. (Pubitemid 46568628)
25. Oni T, Burke R, Tsekela R, et al. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: Implications for TB screening. Thorax 2011; 66:669-73.
26. Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-Associated tuberculosis: A state of the art review. BMC Infect Dis 2012; 12:103.
27. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. BMJ 2003; 326:41-4. (Pubitemid 36110721)